- Home
- IMCR vs WKC Comparison
IMCR vs WKC Comparison
Compare IMCR & WKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- WKC
- Stock Information
- Founded
- IMCR 2008
- WKC 1984
- Country
- IMCR United Kingdom
- WKC United States
- Employees
- IMCR N/A
- WKC N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- WKC Oil Refining/Marketing
- Sector
- IMCR Health Care
- WKC Energy
- Exchange
- IMCR Nasdaq
- WKC Nasdaq
- Market Cap
- IMCR 1.8B
- WKC 1.6B
- IPO Year
- IMCR 2021
- WKC N/A
- Fundamental
- Price
- IMCR $33.38
- WKC $25.59
- Analyst Decision
- IMCR Buy
- WKC Hold
- Analyst Count
- IMCR 10
- WKC 5
- Target Price
- IMCR $58.13
- WKC $29.40
- AVG Volume (30 Days)
- IMCR 315.0K
- WKC 612.3K
- Earning Date
- IMCR 08-07-2025
- WKC 07-31-2025
- Dividend Yield
- IMCR N/A
- WKC 3.11%
- EPS Growth
- IMCR N/A
- WKC N/A
- EPS
- IMCR N/A
- WKC N/A
- Revenue
- IMCR $356,145,000.00
- WKC $38,747,200,000.00
- Revenue This Year
- IMCR $27.43
- WKC N/A
- Revenue Next Year
- IMCR $8.64
- WKC $1.84
- P/E Ratio
- IMCR N/A
- WKC N/A
- Revenue Growth
- IMCR 26.78
- WKC N/A
- 52 Week Low
- IMCR $23.15
- WKC $22.71
- 52 Week High
- IMCR $39.33
- WKC $31.71
- Technical
- Relative Strength Index (RSI)
- IMCR 49.64
- WKC 37.28
- Support Level
- IMCR $31.02
- WKC $24.99
- Resistance Level
- IMCR $33.73
- WKC $26.05
- Average True Range (ATR)
- IMCR 1.49
- WKC 0.65
- MACD
- IMCR -0.03
- WKC -0.04
- Stochastic Oscillator
- IMCR 44.61
- WKC 22.27
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About WKC World Kinect Corporation
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.